“We are constantly monitoring the safety of vaccines used to prevent COVID-19.

Since the beginning of the application, we have not recorded a single case of death resulting from the use of Russian vaccines against coronavirus, and the frequency of adverse reactions is no more than 0.1%, "Interfax quotes Samoilova.

Earlier, Rospotrebnadzor reported that the vaccine against coronavirus infection COVID-19 "EpiVacCorona" is a safe and effective drug.

It is noted that the State Research Center VB "Vector" has published the results of clinical trials of the vaccine among volunteers aged 18-60 years.